AMRESCO Invests in New Powder Manufacturing Facility to Support Growth in Life Science Business

AMRESCO, LLC, a VWR company and a Life Science leader in the supply and contract manufacturing of high purity biochemicals, reagents and research products, announced that it has invested in a new powder manufacturing facility to support growing global business to Diagnostic, Molecular Biology and Biopharmaceutical companies. AMRESCO’s investment is part of its ongoing strategy [...]

IDEX Corporation Declares Regular Quarterly Cash Dividend

LAKE FOREST, Ill.-- IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.23 per common share. The next dividend will be paid July 31, 2013 to shareholders of record as of July 17, 2013. This dividend represents the company’s 75th consecutive regular quarterly cash dividend payment.

Sage Science and Uniscience do Brasil Enter Into Brazilian Distribution Agreement

BEVERLY, Mass. AND SAO PAULO —— Sage Science, a developer of products for improving sample preparation processes in life science applications, and Uniscience do Brasil, the leading distributor of equipment and reagents to the Brazilian biotechnology and molecular biology markets, today announced a distribution agreement for Sage’s Pippin DNA size selection product portfolio. Uniscience is [...]

NanoString Technologies Prices Initial Public Offering

SEATTLE, Wash. – NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of its initial public offering of 5.4 million shares of common stock at a price to the public of $10.00 per share. In addition, the Company has granted the underwriters a 30-day [...]

3D Spheroid Assays for Cancer Drug Screening

AMSBIO has introduced a new range of 96-well format 3D Spheroid Cell Proliferation / Viability Assays, providing a new tool to allow cell-based assays to be carried out in 3D. The new AMSBIO 3D Spheroid Proliferation/Viability Assay provides a useful tool for modeling tumor response in vitro. The kit utilises a 3D Culture Qualified 96 [...]

BioLife Solutions Announces Strategic Partnership with HemaCare

BOTHELL, Wash., -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic [...]

The Institute of Water Resources & Water Supply at TU-Hamburg-Harburg implements Nanoparticle Tracking Analysis to characterize colloids in water.

Salisbury, UK,: NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being implemented for the further characterization of natural colloids (inorganic and organic) at the Institute of Water Resources and Water Supply at the Technical University Hamburg-Harburg in Germany. Inorganic and organic colloids are widespread in aquatic systems, where they influence many water quality treatment [...]

Simulations Plus Signs Material Transfer Agreement with National Institute of Environmental Health Sciences

LANCASTER, Calif.-- Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that it has signed a Material Transfer Agreement (MTA) with the Division of the National Toxicology Program (DNTP) of the U.S. National Institute of Environmental Health Sciences (NIEHS) to provide licenses for its GastroPlus™, [...]

BioFire Receives FDA Clearance for the FilmArray® Blood Culture Identification Panel

SALT LAKE CITY - BioFire Diagnostics, Inc., announced today the FDA clearance of its FilmArray Blood Culture Identification (BCID) Panel. To date, the 27-target panel is the most comprehensive test to be approved by the FDA. The FilmArray BCID Panel provides results from positive blood cultures, and can identify more than 100 blood pathogens known [...]

Miltenyi Biotec receives manufacturing license for therapeutic antibody MB101

TETEROW, GERMANY, — Miltenyi Biotec GmbH today announced that the German medical regulatory authorities, the Arzneimittelüberwachungsbehörde (AMÜSt) of Mecklenburg-Vorpommern and the Paul-Ehrlich-Institut (PEI), have granted a license for the manufacture of the clinical lead candidate, MB101, at its GMP facility in Teterow, Germany. MB101 is a proprietary humanized, monoclonal antibody directed against an undisclosed target [...]

Access IBO on Knowledge Center